Header Logo

Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers.

Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers. Int J Radiat Oncol Biol Phys. 2021 12 01; 111(5):e54-e62.

View in: PubMed